NOTR Quote, Financials, Valuation and Earnings

Ladybug Resource Group has a net margin of 9.81% compared to Nowtransit's net margin of --. Nowtransit's return on equity of 28.6% beat Ladybug Resource Group's return on equity of --.

Nowtransit has a consensus price target of --, signalling downside risk potential of --. On the other hand Ladybug Resource Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Nowtransit has higher upside potential than Ladybug Resource Group, analysts believe Nowtransit is more attractive than Ladybug Resource Group.

Nowtransit has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ladybug Resource Group has a beta of -9.829, suggesting its less volatile than the S&P 500 by 1082.903%.

Nowtransit has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ladybug Resource Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nowtransit pays -- of its earnings as a dividend. Ladybug Resource Group pays out -- of its earnings as a dividend.

Nowtransit quarterly revenues are $573K, which are larger than Ladybug Resource Group quarterly revenues of --. Nowtransit's net income of $56.2K is higher than Ladybug Resource Group's net income of --. Notably, Nowtransit's price-to-earnings ratio is 7,107.71x while Ladybug Resource Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nowtransit is 350.40x versus -- for Ladybug Resource Group. Usually stocks with elevated PS ratios are considered overvalued.

Medicine Man Technologies has a net margin of 9.81% compared to Nowtransit's net margin of -32.23%. Nowtransit's return on equity of 28.6% beat Medicine Man Technologies's return on equity of -39.36%.

Nowtransit has a consensus price target of --, signalling downside risk potential of --. On the other hand Medicine Man Technologies has an analysts' consensus of -- which suggests that it could grow by 13101.65%. Given that Medicine Man Technologies has higher upside potential than Nowtransit, analysts believe Medicine Man Technologies is more attractive than Nowtransit.

Nowtransit has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Medicine Man Technologies has a beta of 1.838, suggesting its more volatile than the S&P 500 by 83.805%.

Nowtransit has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Medicine Man Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nowtransit pays -- of its earnings as a dividend. Medicine Man Technologies pays out -- of its earnings as a dividend.

Nowtransit quarterly revenues are $573K, which are smaller than Medicine Man Technologies quarterly revenues of $43.2M. Nowtransit's net income of $56.2K is higher than Medicine Man Technologies's net income of -$13.9M. Notably, Nowtransit's price-to-earnings ratio is 7,107.71x while Medicine Man Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nowtransit is 350.40x versus 0.01x for Medicine Man Technologies. Usually stocks with elevated PS ratios are considered overvalued.

SunLink Health Systems has a net margin of 9.81% compared to Nowtransit's net margin of -6.93%. Nowtransit's return on equity of 28.6% beat SunLink Health Systems's return on equity of -5.08%.

Nowtransit has a consensus price target of --, signalling downside risk potential of --. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that Nowtransit has higher upside potential than SunLink Health Systems, analysts believe Nowtransit is more attractive than SunLink Health Systems.

Nowtransit has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.404, suggesting its more volatile than the S&P 500 by 40.425%.

Nowtransit has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nowtransit pays -- of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.

Nowtransit quarterly revenues are $573K, which are smaller than SunLink Health Systems quarterly revenues of $7.9M. Nowtransit's net income of $56.2K is higher than SunLink Health Systems's net income of -$549K. Notably, Nowtransit's price-to-earnings ratio is 7,107.71x while SunLink Health Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nowtransit is 350.40x versus 0.17x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.

Walgreens Boots Alliance has a net margin of 9.81% compared to Nowtransit's net margin of 0.95%. Nowtransit's return on equity of 28.6% beat Walgreens Boots Alliance's return on equity of -24.93%.

Nowtransit has a consensus price target of --, signalling downside risk potential of --. On the other hand Walgreens Boots Alliance has an analysts' consensus of -- which suggests that it could grow by 12.7%. Given that Walgreens Boots Alliance has higher upside potential than Nowtransit, analysts believe Walgreens Boots Alliance is more attractive than Nowtransit.

Nowtransit has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Walgreens Boots Alliance has a beta of 0.664, suggesting its less volatile than the S&P 500 by 33.636%.

Nowtransit has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Walgreens Boots Alliance offers a yield of 10.88% to investors and pays a quarterly dividend of $0.25 per share. Nowtransit pays -- of its earnings as a dividend. Walgreens Boots Alliance pays out -14.59% of its earnings as a dividend.

Nowtransit quarterly revenues are $573K, which are smaller than Walgreens Boots Alliance quarterly revenues of $36.4B. Nowtransit's net income of $56.2K is lower than Walgreens Boots Alliance's net income of $344M. Notably, Nowtransit's price-to-earnings ratio is 7,107.71x while Walgreens Boots Alliance's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nowtransit is 350.40x versus 0.05x for Walgreens Boots Alliance. Usually stocks with elevated PS ratios are considered overvalued.